Non-Inferiority of Once-Daily Cobicistat-Boosted Darunavir Versus Ritonavir-Boosted Darunavir in Hiv-1-infected Adult Patients: An Adjusted Comparative Analysis of Pooled Phase 3 Data.

Van Sanden, S; Thilakarathne, P; Opsomer, M; Mrus, J; Vanveggel, S; Lathouwers, E; Adriaenssen, I

Van Sanden, S; Thilakarathne, P; Opsomer, M; Mrus, J; Vanveggel, S; Lathouwers, E; Adriaenssen, I.

Afiliación

Van Sanden S; Janssen Infectious Diseases BVBA, Beerse, Belgium.
Thilakarathne P; Janssen Infectious Diseases BVBA, Beerse, Belgium.
Opsomer M; Janssen Infectious Diseases BVBA, Beerse, Belgium.
Mrus J; Janssen Global Services, Titusville, NJ, USA.
Vanveggel S; Janssen Infectious Diseases BVBA, Beerse, Belgium.
Lathouwers E; Janssen Infectious Diseases BVBA, Beerse, Belgium.
Adriaenssen I; Janssen Global Services, Beerse, Belgium.

Value Health ; 17(7): A664, 2014 Nov.

Article en En | MEDLINE | ID: mdl-27202422

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2014 Tipo del documento: Article País de afiliación: Bélgica

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google